These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19268063)

  • 1. Successful desensitisation to Anastrozole.
    Rodrigues J; Malheiro D; Botelho C; Cruz MC; Castel-Branco MG
    Allergol Immunopathol (Madr); 2009; 37(1):50-1. PubMed ID: 19268063
    [No Abstract]   [Full Text] [Related]  

  • 2. Is long-term adjuvant treatment of breast cancer with anastrozole indicated?
    Doggrell SA
    Expert Opin Pharmacother; 2008 Jun; 9(9):1619-22. PubMed ID: 18518790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal women.
    Vergote I;
    Eur J Cancer; 2002 Nov; 38 Suppl 6():S57-8. PubMed ID: 12409076
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.
    Nabholtz JM
    Am J Hosp Palliat Care; 2004; 21(6):457-65. PubMed ID: 15612238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anastrozole and quinapril can be safely coadministered to elderly women with breast cancer and hypertension: a pharmacokinetic study.
    Repetto L; Vannozzi O; Hazini A; Sestini A; Pietropaolo M; Rosso R
    Ann Oncol; 2003 Oct; 14(10):1587-8. PubMed ID: 14504062
    [No Abstract]   [Full Text] [Related]  

  • 7. Anastrozole: licence extension. No advantage over tamoxifen in advanced-stage breast cancer.
    Prescrire Int; 2001 Jun; 10(53):76-7. PubMed ID: 11718168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
    Boccardo F; Rubagotti A; Puntoni M; Guglielmini P; Amoroso D; Fini A; Paladini G; Mesiti M; Romeo D; Rinaldini M; Scali S; Porpiglia M; Benedetto C; Restuccia N; Buzzi F; Franchi R; Massidda B; Distante V; Amadori D; Sismondi P
    J Clin Oncol; 2005 Aug; 23(22):5138-47. PubMed ID: 16009955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of randomized controlled trials comparing the efficacy and safety of anastrozole versus tamoxifen for breast cancer.
    Yang Y; Pan W; Tang X; Wu S; Sun X
    Oncotarget; 2017 Jul; 8(29):48362-48374. PubMed ID: 28415634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemic crisis associated with anastrozole use in a patient with breast cancer and primary hyperparathyroidism.
    Yu R
    Endocrine; 2016 Sep; 53(3):868-9. PubMed ID: 27369187
    [No Abstract]   [Full Text] [Related]  

  • 11. Anastrozole-induced hepatotoxicity.
    Zapata E; Zubiaurre L; Bujanda L; Piérola A
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1233-4. PubMed ID: 17033446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. World's largest breast cancer treatment trial supports anastrozole use.
    Oncology (Williston Park); 2002 Jan; 16(1):63. PubMed ID: 11831610
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
    Karagöz B; Ayata A; Bilgi O; Uzun G; Unal M; Kandemir EG; Ozgün A; Türken O
    Onkologie; 2009 Jul; 32(7):421-3. PubMed ID: 19556821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anastrozole: brain draining or sparing?
    Berga SL
    Lancet Oncol; 2008 Oct; 9(10):913-4. PubMed ID: 19071243
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term outcomes of aromatase inhibition for breast cancer.
    Toi M
    Lancet Oncol; 2008 Jan; 9(1):8-10. PubMed ID: 18177815
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
    Howell A; Cuzick J; Baum M; Buzdar A; Dowsett M; Forbes JF; Hoctin-Boes G; Houghton J; Locker GY; Tobias JS;
    Lancet; 2005 Jan 1-7; 365(9453):60-2. PubMed ID: 15639680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapy.
    Valakh V; Trombetta MG; Werts ED; Labban G; Khalid MK; Kaminsky A; Parda D
    Am J Clin Oncol; 2011 Jun; 34(3):245-8. PubMed ID: 20622644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of hormone therapy on cognition in breast cancer.
    Shilling V; Jenkins V; Fallowfield L; Howell T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):405-12. PubMed ID: 14623538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-generation aromatase inhibitors in the treatment of advanced breast cancer.
    Nabholtz JM; Reese DM
    Breast Cancer; 2001; 8(4):305-9. PubMed ID: 11791122
    [No Abstract]   [Full Text] [Related]  

  • 20. Anastrozole-induced subacute cutaneous lupus erythematosus.
    Trancart M; Cavailhes A; Balme B; Skowron F
    Br J Dermatol; 2008 Mar; 158(3):628-9. PubMed ID: 18070201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.